NEW YORK (TheStreet) -- CHANGE IN RATINGS

Best Buy

(BBY) - Get Report

upgraded at Goldman to Buy from Neutral on product cycle recovery. Price target inflated to $47 from $44. 2010 and 2011 EPS estimates increased to $3.33 and $3.53, respectively.

Cintas

(CTAS) - Get Report

downgraded at Barclays to Underweight from Equal Weight as fundamentals do not justify valuation. 2010 and 2011 EPS estimate set at $1.46 and $1.50, respectively. Maintain $21 price target.

DirecTV

(DTV)

downgraded at Citi to Hold from Buy as most good news is priced in. Maintain $38 target. 2010 and 2011 EPS estimates set at $2.27 and $3.20, respectively.

F5 Networks

(FFIV) - Get Report

downgraded at BofA/Merrill from Buy to Neutral. Valuation call, based on a $65 price target.

Humana

(HUM) - Get Report

downgraded at Argus from Buy to Hold. $46 price target. Company could lose Tricare contract and see changes in Medicare funding.

ITT

(ITT) - Get Report

downgraded at BofA/Merrill from Buy to Underperform. $58 price target. Estimates also lowered, as the company has relatively less cyclical earnings leverage.

Palm

(PALM)

price target cut at Barclays to $4.50 from $7 as inventory overhand is a major challenge. 2010 and 2011 EPS estimates sunk to -$1.49 and -$1.15, respectively. Equal Weight rating.

Palm

(PALM)

downgraded at Kaufman PALM was downgraded from Hold to Sell. $3 price target. Company may not be profitable for the next 4-6 quarters, and will likely have to raise more capital.

Synaptics

(SYNA) - Get Report

downgraded at Oppenheimer from Outperform to Perform. Channel checks suggest that the mobile business is struggling.

Integrys Energy Group

(TEG)

downgraded at Citi to Sell from Hold on valuation. Price target raised to $42 from $40. 2010 EPS estimate cut to $2.98, 2011 increased to $3.20.

STOCK COMMENTS / EPS CHANGES

Agilent Technologies

(A) - Get Report

numbers boosted at Credit Suisse. Price target lifted to $40 from $36 as the close of VARI acquisition is imminent, Credit Suisse said. 2010 and 2011 EPS estimates raised to $1.75 and $2.28, respectively. Maintain Outperform rating.

Boston Scientific

(BSX) - Get Report

estimates lowered at BofA/Merrill through 2011. ICD recall will hurt profits. Neutral rating and $10 price target.

CVS Caremark

(CVS) - Get Report

estimates cut at Credit Suisse. CVS 2010 and 2011 EPS estimates lowered to $2.74 and $3.07, respectively. Reiterate Outperform rating and $37 price target.

FedEx

(FDX) - Get Report

numbers raised at Goldman FDX price target increased to $102 from $95 after a strong 4Q10. Estimates raised through 2012. Maintain Neutral rating.

FedEx

(FDX) - Get Report

target, estimates boosted at Barclays. Price target increased to $106 from $98. 2010 and 2011 EPS estimates raised to $3.71 and $5.20, respectively. Reiterate Overweight rating.

Jabil Circuits

(JBL) - Get Report

numbers boosted at RBC. Shares of JBL now seen reaching $22. Estimates also raised, as the company should be able to grow its margins in the near term.

Limited Brands

(LTD)

target, estimates raised at Barclays. LTD shares now seen reaching $33, up from $26. Barclays noted strong cash flow. 2010 and 2011 EPS estimates lifted to $1.63 and $2.00, respectively. Overweight rating.

Sunpower

(SPWRA)

price target cut at Citi. SPWRA price target lowered to $15 from $18. Maintain Sell rating. 2010 and 2011 EPS estimates increased to $1.16 and $1.56, respectively.

Sunpower

(SPWRA)

estimates, target lowered at FBR. Shares of SPWRA now seen reaching $22. Estimates also cut, as the company is realizing lower margins. Market Perform rating.

Sempra Energy

(SRE) - Get Report

price target lower at Goldman. SRE price target cut to $52 from $55 as full JV sale presents downside risk to EPS. Estimates lowered through 2012. Neutral rating.

STR Holdings

(STRI)

price target boosted at Goldman to $17 from $15 on higher volume and revenue growth anticipated in 1H10. 2010 and 2011 EPS estimates set at 73 cents and 83 cents, respectively. Maintain Neutral rating.

Triquint Semiconductor

(TQNT)

target, estimates higher at Barclays. Price target raised by a dollar to $9 after positive analyst day. Maintain Overweight rating. 2010 and 2011 EPS estimates improved to 60 cents and 70 cents, respectively.

Walgreen

(WAG)

estimate lower at Credit Suisse. WAG 2010 EPS estimate fell by 2 cents to $2.23, 2011 set at $2.70. Near-term outlook is challenging. Maintain Outperform rating and $42 price target.

WNS Holdings

(WNS) - Get Report

target, estimates lowered at Goldman. WNS price target sunk to $14.50 from $16.50 on lower revenue growth into 2011. Neutral rating. Estimates lowered through 2012.

This article was written by a staff member of TheStreet.com.